Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

辉瑞和诺和诺德在减肥药物领域的百亿美元争夺战

Behind the Money

2025-11-12

26 分钟
PDF

单集简介 ...

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multibillion-dollar battle for control of biotech start-up Metsera. The FT’s US deals and activism correspondent Oliver Barnes walks through the tussle that’s involved lawsuits, public barbs and political drama. Clips from CNBC, Pfizer, Yahoo Finance - - - - - - - - - - - - - - - - - - - - - - - - - -  For further reading and listening: Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk Pfizer shows hardball mettle needed to win in 2025 M&A There is only one winner in the Pfizer Novo Nordisk showdown Ozempic’s unconventional origins - - - - - - - - - - - - - - - - - - - - - - - - - -  Attend the FT Global Banking Summit, 2-4 December in London: Enter SAVE20 for a 20% discount, register here. - - - - - - - - - - - - - - - - - - - - - - - - - -  Follow Oliver Barnes on X (@mroliverbarnes), or on Bluesky (@mroliverbarnes.bsky.social) Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
更多

单集文稿 ...

  • Balance your trading strategy by adding futures.

  • CME Group helps you manage risk and capture opportunities in all market environments.

  • Capitalize on around-the-clock access to highly liquid global futures and options markets across all major asset classes.

  • Visit your online broker and get started.

  • See what adding futures can do for you at cmegroup.com slash podcast.

  • Derivatives are not suitable for all investors and involve the risk of losing more than the amount originally deposited and any profits you might have made.

  • This is not a recommendation to offer to buy, sell, or retain any specific investment or service.

  • Hi everyone, it's Michaela.

  • Before we start today's show,

  • I wanted to let you know that I'll be in London this December for the FT's Global Banking Summit.

  • The event will feature CEOs, top regulators,

  • and policy leaders

  • as they discuss everything from geopolitical risk to exploring the future of AI and finance.

  • And I'll be hosting a few panels myself.

  • The summit runs from the 2nd to the 4th of December.

  • If you want to register, you can find more information in our show notes,

  • including a discount code for 20% off.

  • See you there.

  • Last week, Two pharma giants found themselves locked in a ferocious battle.

  • Pfizer and Novo Nordis duped it out for who will own Metzera,